Innovacell (TSE:504A) OCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:504A Innovacell Inc TSE:504A
10 GF Score
Price 円453.00
View Full Analysis

What is Innovacell OCF Margin %?

Innovacell TSE:504A -7.93% 10 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:504A with a GF Score™ of 10/100. Among 950 Biotechnology companies, Innovacell ranks worse than 105263.05% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Innovacell's Cash Flow from Operations for the three months ended in Dec. 2025 was 円0.00 Mil. Innovacell's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, Innovacell's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Innovacell's current OCF Yield % is -8.99%.

The historical rank and industry rank for Innovacell's OCF Margin % or its related term are showing as below:


TSE:504A's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -64.565
* Ranked among companies with meaningful OCF Margin % only.

Innovacell OCF Margin % Related Terms

Innovacell OCF Margin % Historical Data

* Premium members only.

The historical data trend for Innovacell's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovacell OCF Margin % Chart

Innovacell Annual Data
Trend Dec23 Dec24 Dec25
OCF Margin %
0.00 0.00 0.00

Innovacell Quarterly Data
Dec23 Dec24 Sep25 Dec25 Mar26
OCF Margin % 0.00 0.00 0.00 0.00 0.00
TSE:504A
10GF Score
Innovacell Inc TSE:504A
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovacell OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Innovacell's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1995.296/0
= %

Innovacell's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Innovacell (TSE:504A) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Innovacell and its competitors. According to the industry distribution chart, Innovacell ranks #999999 out of 950 companies in the Biotechnology industry.
Is Innovacell's OCF Margin % too high?
Innovacell's current OCF Margin % is 0.00%. Based on the distribution chart, Innovacell ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Innovacell has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Innovacell's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Innovacell ranks #999999 out of 950 companies for OCF Margin %. This places Innovacell in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Innovacell and its competitors. Innovacell's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovacell stock overvalued right now?
Innovacell (TSE:504A) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Innovacell's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Innovacell (TSE:504A), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovacell Business Description

Address 3-5-11 Kamiosaki, Meguro Villa Garden, 5th floor, Shinagawa-ku, Tokyo, JPN, 141-0021
Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Its activities include researching potential therapeutic candidates, developing formulations, and commercializing products in the markets. The company is working on the development and commercialization of the following three cell therapy pipelines targeting incontinence (fecal and urinary incontinence): ICEF15, ICEF16, and ICES13.
10GF Score

Get the complete analysis for TSE:504A

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円453.00
Price